PCR Fluorescence
-
Ụdị 28 nke Nje Virus papilloma mmadụ nwere nnukwu ihe ize ndụ (16/18 typing) Nucleic acid
Ngwa a dabara adaba maka nchọpụta qualitative in vitro nke ụdị nje papilloma mmadụ 28 (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 45, 5, 5, 5, 5, 5, 5, 5, 45, 45, 5, 5, 5, 5, 5, 5, 5, 5, 45, 45, 45, 45, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5). 61, 66, 68, 73, 81, 82, 83) nucleic acid n'ime mmamịrị nwoke / nwanyị na sel nwanyị exfoliated cervical. Enwere ike ịdepụta HPV 16/18, ụdị ndị fọdụrụ enweghị ike ịdepụta kpamkpam, na-enye ụzọ enyemaka maka nyocha na ọgwụgwọ nke ọrịa HPV.
-
Ụdị 28 nke HPV Nucleic Acid
The kit is used for the in vitro qualitative detection of 28 types of human papillomaviruses (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53 , 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid n'ime nwoke / mmamịrị nwanyị na mkpụrụ ndụ exfoliated nwanyị, mana enweghị ike idezi nje ahụ kpamkpam.
-
Papillomavirus mmadụ (ụdị 28) Genotyping
A na-eji ngwa a maka nchọpụta qualitative na genotyping nke nucleic acid nke ụdị 28 nke papillomavirus mmadụ (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 43, 44, 45, 51, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5, 5. 59, 61, 66, 68, 73, 81, 82, 83) n'ime mmamịrị nwoke / nwanyị na ụmụ nwanyị exfoliated cervical, na-enye ụzọ enyemaka maka nchọpụta na ọgwụgwọ nke ọrịa HPV.
-
Enterococcus na-eguzogide Vancomycin na Gene na-eguzogide ọgwụ
A na-eji ngwa a maka nchọpụta qualitative nke vancomycin na-eguzogide enterococcus (VRE) na mkpụrụ ndụ ihe nketa na-eguzogide ọgwụ VanA na VanB na sputum mmadụ, ọbara, mmamịrị ma ọ bụ obodo dị ọcha.
-
Mmadụ CYP2C9 na VKORC1 Gene Polymorphism
Ngwa a na-emetụta in vitro qualitative nchọpụta nke polymorphism nke CYP2C9*3 (rs1057910, 1075A>C) na VKORC1 (rs9923231, -1639G>A) na genomic DNA nke mmadụ dum ọbara samples.
-
Mmadụ CYP2C19 Gene Polymorphism
A na-eji ngwa a maka nchọpụta qualitative in vitro nke polymorphism nke mkpụrụ ndụ ihe nketa CYP2C19 CYP2C19 * 2 (rs4244285, c.681G>A), CYP2C19 * 3 (rs4986893, c.636G>A), CYP2C12 * 14.6 (cYP2C19*10) DNA genomic nke ihe nlele ọbara mmadụ dum.
-
Leukocyte Antigen B27 Nucleic Acid mmadụ
A na-eji ngwa a maka nchọpụta qualitative nke DNA na subtypes antigen leukocyte mmadụ HLA-B*2702, HLA-B*2704 na HLA-B*2705.
-
Nje Virus Nucleic Acid
A na-eji ngwa a maka nchọpụta qualitative in vitro nke nje nucleic acid n'ime mmiri ọkụ ọkụ mmadụ, swabs nasopharyngeal, akpịrị akpịrị na ihe nlele ọbara.
-
Ureaplasma Urealyticum Nucleic Acid
Ngwa a dabara adaba maka nchọpụta qualitative nke Ureaplasma urealyticum (UU) n'ime ụmụ nwoke na ụmụ nwanyị na-emepụta ihe nzuzo nzuzo na vitro.
-
MTHFR Gene Polymorphic Nucleic Acid
A na-eji ngwa a chọpụta saịtị mmụgharị abụọ nke mkpụrụ ndụ MTHFR. Ngwa ahụ na-eji ọbara mmadụ dum dị ka ihe nlele ule iji nye nlebanya qualitative nke ọnọdụ mmụgharị. Ọ nwere ike inyere ndị dọkịta aka chepụta atụmatụ ọgwụgwọ dabara adaba maka njirimara dị iche iche nke onye ọ bụla site na ọkwa molekụla, iji hụ na ahụike nke ndị ọrịa ruo oke.
-
Mmadu BRAF Gene V600E
A na-eji ngwa ule a chọpụta nke ọma ngbanwe BRAF gene V600E n'ụdị anụ ahụ agbakwunyere nke paraffin nke melanoma mmadụ, ọrịa cancer colorectal, kansa thyroid na ọrịa cancer akpa ume na vitro.
-
Mmadụ BCR-ABL Fusion Gene Mutation
Ngwa a dabara adaba maka nchọpụta qualitative nke p190, p210 na p230 isoforms nke BCR-ABL fusion gene na ụmị ọkpụkpụ mmadụ.
